ZX-22102-250 (250 RXNS) | SARS-CoV-2 – RT-qPCR Detection kit (N&RP)
A novel human coronavirus, currently named 2019-nCoV, causes ongoing pneumonia outbreak which started in Wuhan City in China. The 2019-nCoV is genetically different from other common human coronaviruses such as 229E, NL63, OC43 and HKU1 that cause seasonal acute respiratory illnesses. It is also genetically distinct from the two newer human coronaviruses, MERS-CoV and SARS-CoV.
The ZellX® 2019-nCoV RT-qPCR Kit is designed for quantitative in vitro detection of 2019-nCoV using real time RT-PCR in respiratory specimens (sputum; nasopharyngeal, oropharyngeal aspirates, washes or swabs and tracheal aspirates). To prevent the degradation of viral RNA by RNases, our kit comes with a vial of Ribonuclease (RNAse) inhibitor.
The ZellX® RT-qPCR Kit allows efficient cDNA synthesis and Real-Time PCR in a single tube. The qPCR Master Mix provided in the kit contains all the reagent (except RNA template) needed for running PCR reactions. In addition, a separate Reverse Transcriptase is supplied.
Designed based on CDC guideline for SARS-CoV-2 real-time PCR detection
Use: specific detection of SARS-CoV-2 in less than 2 hours
Sample: Respiratory specimens (Sputum; nasopharyngeal, oropharyngeal aspirates, washes or swabs; tracheal aspirates)
Quantity: 250 rxns
Stability: 2 years at -20°C
Technical Support: Customer satisfaction is very important to us. Please call us at +49(0)30 81309085 or send an email to technical[at]zellx.de with your technical questions. A member of our scientific staff will be glad to assist you.